Chester County News and Community Website
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) recently announced that its Investigational New Drug application (IND) for CT-0525 has been cleared by the U.S. Food and Drug Administration (FDA). …
Carisma Therapeutics Receives FDA Clearance for Groundbreaking CAR-Monocyte Cellular Therapy Read More
The Federal Trade Commission (FTC) recently unveiled its Fiscal Year 2023 Agency Financial Report, spotlighting the agency’s accomplishments in safeguarding consumers and fostering competition. The report also reemphasizes the FTC’s …
FTC Releases Fiscal Year 2023 Agency Financial Report Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) this week announced that the Company’s fourth Investigational New Drug (IND) application for CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational …
Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis Read More
The U.S. Food and Drug Administration recently approved Tibsovo (ivosidenib)Â for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as …
FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes Read More
NEWTOWN SQUARE, PA — ArriVent Biopharma, Inc. announced that the U.S. Food and Drug Administration (FDA) recently granted Breakthrough Therapy designation for furmonertinib for the treatment of patients with previously …
ArriVent Receives FDA Breakthrough Therapy Designation for Furmonertinib Read More
WEST CHESTER, PA — Representative Chrissy Houlahan (D-PA) announced her office recently crossed a major milestone: $50 million returned directly to community members and small businesses through her office’s constituent …
Houlahan’s Impact: Returning $50 Million to Constituents Through Her Office’s Efforts Read More